Trademark Details For Serial Number 85765001

  •  Home
  •  Print
0
0
0
0
Basic Information
Serial Number  United States - USPTO 85765001
Registration Number 4357840
Filing Date Oct-26-2012
Status
Registered  
REGISTERED A.. (800)
REGISTERED AND RENEWED
Attorney Name
TTAB
0


  • HOSPITAL FOR SPECIAL SURGERY

  • Description Of Mark:
  • Color(s) Claimed:

044Medical, beauty and agricultural

U.S Class(es): 100, 101

Class Status: Active

First Use: Oct-26-2012

First Use in Commerce: Oct-26-2012


02.01.33
02.05.05
02.05.26
02.07.01
02.07.04
02.07.26
04.07.03
26.01.15
26.01.21
26.17.02
26.17.05



Correspondences

NameBela Amladi
AddressPROSKAUER ROSE LLP Eleven Times Square NEW YORK, NY 10036-8299

Prosecution History

USPTO 
DateDescription
Action Tags    
Action tags indicate key events in the prosecution history. View details of the related office action file by clicking on the icons.
Code
Oct-31-2012NEW APPLICATION ENTERED   NWAPI
Nov-01-2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED   NWOSI
Nov-02-2012NOTICE OF DESIGN SEARCH CODE MAILED   MDSCO
Feb-25-2013ASSIGNED TO EXAMINER   DOCKD
Feb-28-2013APPROVED FOR PUB - PRINCIPAL REGISTER   CNSAO
Mar-20-2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED   NONPE
Apr-09-2013PUBLISHED FOR OPPOSITION   PUBOA
Apr-09-2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED   NPUBE
Jun-25-2013REGISTERED-PRINCIPAL REGISTER   R.PRA
Jun-25-2018COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED   REM1E
Jan-31-2019TEAS SECTION 8 & 15 RECEIVED   E815I
Mar-09-2019CASE ASSIGNED TO POST REGISTRATION PARALEGAL   APREA
Mar-09-2019REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.   C15AO
Mar-09-2019NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED   NA85E
Jun-25-2022COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED   REM2E
Jul-11-2022TEAS SECTION 8 & 9 RECEIVED   E89RI
Jan-26-2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL   APREA
Jan-26-2023REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED   89AGO
Jan-26-2023REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)   RNL1Q
Jan-26-2023NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED   NA89E